Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
08/18/2005 | WO2005075413A1 Method for producing guanidinium salts |
08/18/2005 | WO2005047242A3 Compounds containing thiosulfate moieties |
08/18/2005 | WO2005040345A3 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
08/18/2005 | WO2005030794A3 Hemiasterlin derivatives and uses thereof |
08/18/2005 | WO2004100873A3 Compounds, compositions, and methods |
08/18/2005 | WO2004092224A3 Polymerisation initiator system |
08/18/2005 | US20050182110 tetracylic bridged ring compounds such as 9-nitro-11-amino-11-((imidazol-2-yl)aminocarbonyl)-9,10-dihydro-9,10-ethanoanthracene; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB) |
08/18/2005 | US20050180953 peptides derivatives as an agent inducing cells differentiation and in particular, to their use in antitumor noncytotoxic therapy; melanoma; most preferred compound used in the present invention is 4-[N-(2-imidazol-4-yl)ethyl)carbamoyl]butyric acid (Dicarbamine (reg) ) |
08/18/2005 | DE102004001413A1 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of chronic obstructive pulmonary disease |
08/18/2005 | CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase |
08/18/2005 | CA2554796A1 Modulators of atp-binding cassette transporters |
08/17/2005 | EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses |
08/17/2005 | EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
08/17/2005 | EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
08/17/2005 | EP1562910A1 Celecoxib prodrug |
08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
08/17/2005 | EP1202945B1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
08/17/2005 | CN1656109A Non nucleoside reverse transcriptase inhibitors |
08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
08/17/2005 | CN1654455A Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
08/16/2005 | US6930076 Nematicidal trifluorobutenyl imidazole thioether derivatives |
08/11/2005 | WO2005072729A1 Modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
08/11/2005 | WO2005072132A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
08/11/2005 | WO2005072082A2 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
08/11/2005 | WO2005058840A3 Method of coloring with capped diazotized compound and coupling component |
08/11/2005 | WO2005023422A3 Production and use of ionic liquids containing thiocyanato anions |
08/11/2005 | WO2004110983A8 New benzamides as pparϒ modulators |
08/11/2005 | WO2004014847A8 Mcp-1 receptor antagonists and method of use thereof |
08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
08/11/2005 | US20050176821 Meta-substituted phenylene sulphonamide derivatives |
08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
08/11/2005 | US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity |
08/11/2005 | US20050175867 Room-temperature molten salt, process for producing the same and applications thereof |
08/11/2005 | DE102004003958A1 Herstellungsmethode für ionische Flüssigkeiten Method of preparation of ionic liquids |
08/11/2005 | DE102004003811A1 Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Cyclohexylimidazolinone, processes for their preparation and their use as medicaments |
08/10/2005 | EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases |
08/10/2005 | EP1561741A1 Method for deuteration or tritiation of heterocyclic ring |
08/10/2005 | EP1333795A4 Novel coupler for use in oxidative hair dyeing |
08/10/2005 | CN1653052A Novel imidazole compounds, method for preparing same and use thereof as medicines |
08/10/2005 | CN1652775A Peptide deformylase inhibitors |
08/10/2005 | CN1651443A Monophosphine ligand having C2 symmetric skeleton, synthesis method and application |
08/10/2005 | CN1651415A Preparation and purification method of ornidazole optical antipode |
08/10/2005 | CN1214012C Method for producing carbonyl dimidazoles |
08/10/2005 | CN1214004C Process for producing arylsulfenyl halide |
08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
08/09/2005 | US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method |
08/09/2005 | CA2303217C Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
08/04/2005 | WO2005070898A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect |
08/04/2005 | WO2005070897A1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof |
08/04/2005 | WO2005070896A1 Mehtod for producing ionic liquids |
08/04/2005 | WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof |
08/04/2005 | WO2005041853A3 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
08/04/2005 | WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors |
08/04/2005 | US20050171163 MCP-1 receptor antagonists and methods of use thereof |
08/04/2005 | US20050171154 Carboxylic acid amides |
08/04/2005 | US20050171136 Modulators of the glucocorticoid receptor and method |
08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
08/04/2005 | US20050171081 1,3-bis(phenylmethyl)-4,5-dimethyl-1H-imidazlium chloride; 1,3-bis(phenylmethyl)-2,4,5-trimethyl-1H-imidazolium chloride; anticancer; antiproliferative; high yield and purity |
08/04/2005 | CA2554233A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect |
08/03/2005 | EP1559718A1 Combretastatin A-4 phosphate prodrug salts with nitrogen-containing compounds |
08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
08/03/2005 | EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
08/03/2005 | EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
08/03/2005 | EP1558082A1 Biocidal composition containing halogenated hydantoin and paraffin wax |
08/03/2005 | EP1357124B1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
08/03/2005 | CN1649885A Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
08/03/2005 | CN1649847A Method for producing optically active sulfoxide derivative |
08/03/2005 | CN1649846A Compounds of the family of 3-alkyl-(4, 5-diphenyl-imidazol-1-yl) and their use as soothing agents |
08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
08/03/2005 | CN1649830A Substituted aryl ketones |
08/03/2005 | CN1649829A Novel florfenicol-type antibiotics |
08/03/2005 | CN1649827A Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
08/03/2005 | CN1649820A Compounds that modulate PPAR activity and methods for their preparation |
08/03/2005 | CN1649612A Induction method for cell differentiation |
08/03/2005 | CN1649603A Aqueous compositions containing metronidazole |
08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
08/03/2005 | CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders |
08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
08/03/2005 | CN1213037C Halogenated pyrimidine and its application for reducing parasite |
08/03/2005 | CN1213025C 硫代酰胺衍生物 Thioamide derivatives |
08/03/2005 | CN1213020C Phenylalaninol derivatives |
08/02/2005 | US6924396 α-haloenamine reagents |
08/02/2005 | US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid |
08/02/2005 | US6924376 Compounds, compositions and methods |
08/02/2005 | US6924330 Thioimidazolidine derivatives as light stabilizers for polymers |
08/02/2005 | US6924251 herbicides. |
08/02/2005 | CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
08/02/2005 | CA2102960C Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
07/28/2005 | WO2005068445A2 Pesticidal heterocyclic dihaloallyl compounds |
07/28/2005 | WO2005068432A1 Malononitrile compound as pesticides |
07/28/2005 | WO2005068423A1 Malononitrile compound and use thereof |
07/28/2005 | WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses |
07/28/2005 | WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
07/28/2005 | WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses |
07/28/2005 | WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses |
07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
07/28/2005 | US20050165078 evolution of ammonia is virtually completely avoided; reduction in sublimation of urea, as occurs on reaction in the melt; high purity of the crude product means that further recrystallization is usually unnecessary |